NSAM
TXG icon

North Star Asset Management’s 10x Genomics TXG Stock Holding History

North Star Asset Management’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$988K Sell
25,780
-900
-3% -$23.6K 0.04% 200
2026
Q1 		$566K Sell
26,680
-2,460
-8% -$49.2K 0.02% 235
2025
Q4 		$475K Sell
29,140
-10,842
-27% -$164K 0.02% 246
2025
Q3 		$467K Sell
39,982
-1,111
-3% -$14.5K 0.02% 239
2025
Q2 		$476K Sell
41,093
-6,494
-14% -$59.2K 0.02% 228
2025
Q1 		$415K Sell
47,587
-40
-0.1% -$504 0.02% 232
2024
Q4 		$684K Sell
47,627
-10,359
-18% -$163K 0.03% 198
2024
Q3 		$1.31M Buy
57,986
+4,837
+9% +$100K 0.06% 161
2024
Q2 		$1.03M Buy
53,149
+9,514
+22% +$249K 0.05% 169
2024
Q1 		$1.64M Buy
43,635
+2,986
+7% +$131K 0.08% 144
2023
Q4 		$2.27M Sell
40,649
-1,136
-3% -$49.4K 0.12% 123
2023
Q3 		$1.72M Buy
41,785
+920
+2% +$47.9K 0.1% 136
2023
Q2 		$2.28M Sell
40,865
-210
-0.5% -$11.4K 0.13% 124
2023
Q1 		$2.29M Buy
41,075
+5,126
+14% +$239K 0.13% 121
2022
Q4 		$1.31M Buy
35,949
+1,641
+5% +$53.7K 0.08% 145
2022
Q3 		$977K Sell
34,308
-5,664
-14% -$216K 0.07% 153
2022
Q2 		$1.81M Sell
39,972
-331
-0.8% -$17.2K 0.12% 126
2022
Q1 		$3.07M Buy
40,303
+5,652
+16% +$494K 0.17% 111
2021
Q4 		$5.16M Buy
34,651
+1,902
+6% +$291K 0.26% 91
2021
Q3 		$4.77M Buy
32,749
+10,111
+45% +$1.74M 0.26% 94
2021
Q2 		$4.43M Buy
22,638
+3,104
+16% +$562K 0.25% 96
2021
Q1 		$3.54M Buy
+19,534
New +$3.37M 0.21% 103

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

North Star Asset Management's TXG Position: Q2 2026 in Review

North Star Asset Management reduced its 10x Genomics (TXG) stake by 3.4% in Q2 2026, selling an estimated $23.6K and leaving 25,780 shares worth $988K. The position accounts for 0.04% of the portfolio, ranked #200.

North Star Asset Management first reported a position in TXG in Q1 2021 and has held it in 22 quarters since. The position peaked at $5.16M in Q4 2021. 391 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

  • North Star Asset Management held 25,780 shares of 10x Genomics worth $988K as of Q2 2026.
  • North Star Asset Management sold 900 10x Genomics shares in Q2 2026, an estimated $23.6K.
  • 10x Genomics made up 0.04% of North Star Asset Management's portfolio in Q2 2026, its #200 holding.
  • North Star Asset Management first reported a position in 10x Genomics in Q1 2021 and has held it in 22 quarters since.
  • North Star Asset Management's 10x Genomics position peaked at $5.16M in Q4 2021.
  • 391 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on North Star Asset Management's 13F filing for Q2 2026, filed 18 Aug 2026.